Liver Diseases  >>  irinotecan  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
irinotecan / Generic mfg.
NCT00635323: Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

Completed
2
73
RoW
Irinotecan plus capecitabine
Pfizer
Carcinoma, Hepatocellular
 
05/05
NCT00106054: Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

Terminated
2
2
US
Combination therapy of irinotecan with 5-FU, leucovorin plus bevacizumab in the neoadjuvant setting.
Pfizer
Colorectal Neoplasms, Liver Neoplasms
09/06
09/06
NCT00168155: Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma

Completed
2
70
Canada
perioperative chemotherapy
Alberta Health services, Pfizer
Colorectal Adenocarcinoma, Liver Metastases
05/09
05/09

Download Options